EMEA-001437-PIP02-19

Key facts

Active substance
mifepristone
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0295/2019
PIP number
EMEA-001437-PIP02-19
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of endometriosis
Route(s) of administration
Oral use
Contact for public enquiries
Laboratorios Litaphar S.L.

E-mail: eencinas@dynakin.com
Tel. +34 9440 45504

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating